CHCT financial statements and SEC filings
CHCT annual income statement
| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
|---|
| 2025-12-31 | $121.19M | – | $2.08M | 10-K |
| 2024-12-31 | $115.79M | – | -$5.98M | 10-K |
| 2023-12-31 | $112.84M | – | $5.09M | 10-K |
| 2022-12-31 | $97.68M | – | $19.17M | 10-K |
| 2021-12-31 | $90.58M | – | $20.18M | 10-K |
| 2020-12-31 | $75.68M | – | $17.23M | 10-K |
CHCT annual balance sheet
| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
|---|
| 2025-12-31 | $990.76M | $561.37M | $429.39M | 10-Q |
| 2024-12-31 | $992.56M | $516.60M | $475.96M | 10-K |
| 2023-12-31 | $945.41M | $432.16M | $513.26M | 10-K |
| 2022-12-31 | $876.42M | $379.61M | $496.81M | 10-K |
| 2021-12-31 | $754.23M | $292.12M | $462.11M | 10-K |
| 2020-12-31 | $668.40M | $238.49M | $429.92M | 10-K |
CHCT annual cash flow
| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
|---|
| 2025-12-31 | $56.43M | -$20.52M | -$9.78M | 10-K |
| 2024-12-31 | $58.88M | -$24.64M | $33.53M | 10-K |
| 2023-12-31 | $61.38M | -$18.98M | $44.86M | 10-K |
| 2022-12-31 | $60.28M | -$10.38M | $62.69M | 10-K |
| 2021-12-31 | $56.35M | -$7.22M | $48.05M | 10-K |
| 2020-12-31 | $48.37M | -$7.00M | $77.56M | 10-K |